Cardio diagnostics holdings, inc.CDIO.US Overview

US StockHealthcare

(No presentation for CDIO)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

CDIO Overall Performance

CDIO AI Analysis & Strategy

CDIO Recent Performance

4.06%

Cardio diagnostics holdings, inc.

0.81%

Avg of Sector

-1.14%

S&P500

CDIO PowerScanner

CDIO Key Information

CDIO Valuation Metrics

CDIO Earnings Table

CDIO Profile

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.